Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome

The Inflammasomes

Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475

Gout-associated uric acid crystals activate the NALP3 inflammasome

Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326

Dopamine receptors: from structure to function

MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633

Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression

Bauernfeind, F. G., Horvath, G. L., Stutz, A., Alnemri, E. S., MacDonald, K. L., Speert, D. P., Fernandes‐Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 3,087

The physiology, signaling, and pharmacology of dopamine receptors

Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763

The NALP3 inflammasome is involved in the innate immune response to amyloid-β

Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441

The Inflammasomes: Guardians of the Body

Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436

Comparison of Dopamine and Norepinephrine in the Treatment of Shock

De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940

The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases

Davis, B. K., Wen, H., & Ting, J. P.-Y. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101405 · Cited by 1,618

The therapeutic potential of monoamine oxidase inhibitors

Youdim, M. B. H., Edmondson, D. E., & Tipton, K. F. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1883 · Cited by 1,401

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

Swanson, K. V., Deng, M., & Ting, J. P.-Y. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0165-0 · Cited by 4,884

The NLRP3 Inflammasome: an overview of mechanisms of activation and regulation

Kelley, N., Jeltema, D., Duan, Y., & He, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133328 · Cited by 3,539

Inflammasomes: mechanism of action, role in disease, and therapeutics

Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340

Necroptosis, pyroptosis and apoptosis: an intricate game of cell death

Bertheloot, D., Latz, E., & Franklin, B. S. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00630-3 · Cited by 2,297

Targeting the NLRP3 inflammasome in inflammatory diseases

Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.97 · Cited by 1,885

Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors

Yang, Y., Wang, H., Kouadir, M., Song, H., & Shi, F. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1413-8 · Cited by 1,326

Inflammasome activation and regulation: toward a better understanding of complex mechanisms

Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Discovery · doi:10.1038/s41421-020-0167-x · Cited by 1,078

Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease

Re, D. P. D., Amgalan, D., Linkermann, A., Liu, Q., & Kitsis, R. N. (2019) · Physiological Reviews · doi:10.1152/physrev.00022.2018 · Cited by 994

An update on the regulatory mechanisms of NLRP3 inflammasome activation

Paik, S., Kim, J. K., Silwal, P., Sasakawa, C., & Jo, E. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00670-3 · Cited by 943

Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice

Gordon, R., Albornoz, E. A., Christie, D. C., Langley, M. R., Kumar, V., Mantovani, S., Robertson, A. A. B., Butler, M. S., Rowe, D. B., O’Neill, L. A., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah4066 · Cited by 897

Microglia-mediated neuroinflammation in neurodegenerative diseases

Subhramanyam, C. S., Wang, C., Hu, Q., & Dheen, S. T. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.004 · Cited by 897

Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome

Guo, C., Xie, S., Chi, Z., Zhang, J., Liu, Y., Zhang, L., Zheng, M., Zhang, X., Xia, D., Ke, Y., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.008 · Cited by 838

The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology

Rutsch, A., Kantsjö, J. B., & Ronchi, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604179 · Cited by 821

Inflammasomes in neuroinflammatory and neurodegenerative diseases

Voet, S., Srinivasan, S., Lamkanfi, M., & van Loo, G. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201810248 · Cited by 761

Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications

Pajares, M., I. Rojo, A., Manda, G., Boscá, L., & Cuadrado, A. (2020) · Cells · doi:10.3390/cells9071687 · Cited by 779

Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders

Jiang, H., He, H., Chen, Y., Huang, W., Cheng, J., Ye, J., Wang, A., Tao, J., Wang, C., Liu, Q., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20171419 · Cited by 783

Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasome

Afonina, I. S., Zhong, Z., Karin, M., & Beyaert, R. (2017) · Nature Immunology · doi:10.1038/ni.3772 · Cited by 785

NLRP3 Inflammasome and Inflammatory Bowel Disease

Yu, Z., & Zhang, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00276 · Cited by 671

The NLRP3 inflammasome: activation and regulation

Xu, J., & Núñez, G. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.10.002 · Cited by 679

Artificial Nonenzymatic Antioxidant MXene Nanosheet-Anchored Injectable Hydrogel as a Mild Photothermal-Controlled Oxygen Release Platform for Diabetic Wound Healing

Li, Y., Fu, R., Duan, Z., Zhu, C., & Fan, D. (2022) · ACS Nano · doi:10.1021/acsnano.1c10575 · Cited by 640

Post-Translational Modification Control of Innate Immunity

Liu, J., Qian, C., & Cao, X. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.020 · Cited by 641

The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases

Blevins, H. M., Xu, Y., Biby, S., & Zhang, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.879021 · Cited by 587

Ubiquitination in the regulation of inflammatory cell death and cancer

Cockram, P. E., Kist, M., Prakash, S., Chen, S., Wertz, I. E., & Vucic, D. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00708-5 · Cited by 536

Emerging Activators and Regulators of Inflammasomes and Pyroptosis

Xue, Y., Tuipulotu, D. E., Tan, W. H., Kay, C., & Man, S. M. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.09.005 · Cited by 517

The role of mitochondria in NLRP3 inflammasome activation

Liu, Q., Zhang, D., Hu, D., Zhou, X., & Zhou, Y. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.09.010 · Cited by 475

Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis

Hao, H., Cao, L., Jiang, C., Che, Y., Zhang, S., Takahashi, S., Wang, G., & Gonzalez, F. J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.007 · Cited by 484

The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3

Song, H., Liu, B., Huai, W., Yu, Z., Wang, W., Zhao, J., Han, L., Jiang, G., Zhang, L., Gao, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms13727 · Cited by 466

Inflammasome activation and assembly at a glance

Malik, A., & Kanneganti, T. (2017) · Journal of Cell Science · doi:10.1242/jcs.207365 · Cited by 459

The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease

Wang, S., Yuan, Y., Chen, N., & Wang, H. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.12.019 · Cited by 452

An Acetylation Switch of the NLRP3 Inflammasome Regulates Aging-Associated Chronic Inflammation and Insulin Resistance

He, M., Chiang, H.-H., Luo, H., Zheng, Z., Qiao, Q., Wang, L., Tan, M., Ohkubo, R., Mu, W.-C., Zhao, S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.01.009 · Cited by 425

Small Molecule-Driven NLRP3 Inflammation Inhibition via Interplay between Ubiquitination and Autophagy: Implications for Parkinson Disease

Han, X., Sun, S., Sun, Y., Song, Q., Zhu, J., Song, N., Chen, M., Sun, T., Xia, M., Ding, J., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1596481 · Cited by 408

Role of the NLRP3 inflammasome in cancer

Moossavi, M., Parsamanesh, N., Bahrami, A., Atkin, S. L., & Sahebkar, A. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0900-3 · Cited by 431

MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration

Lee, E., Hwang, I., Park, S., Hong, S., Hwang, B., Cho, Y., Son, J., & Yu, J.-W. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0124-5 · Cited by 431

Mitochondria-associated membranes (MAMs) and inflammation

Missiroli, S., Patergnani, S., Caroccia, N., Pedriali, G., Perrone, M., Previati, M., Wieckowski, M. R., & Giorgi, C. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0027-2 · Cited by 398

The multifunctional protein HMGB1: 50 years of discovery

Tang, D., Kang, R., Zeh, H. J., & Lotze, M. T. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00894-6 · Cited by 405

Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets

Walle, L. V., & Lamkanfi, M. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00822-2 · Cited by 397

Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis

Calabrese, V., Santoro, A., Monti, D., Crupi, R., Di Paola, R., Latteri, S., Cuzzocrea, S., Zappia, M., Giordano, J., Calabrese, E. J., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.379 · Cited by 356

Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease

Caputi, V., & Giron, M. C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061689 · Cited by 338

The therapeutic potential of targeting regulated non-apoptotic cell death

Hadian, K., & Stockwell, B. R. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00749-8 · Cited by 349

Innate Immunity and Neurodegeneration

Labzin, L. I., Heneka, M. T., & Latz, E. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-050715-104343 · Cited by 319

Dopamine, Immunity, and Disease

Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J. R., & Gaskill, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 328

The IL-1β phenomena in neuroinflammatory diseases

Mendiola, A. S., & Cardona, A. E. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1732-9 · Cited by 328

NLRP3 inflammasome in neuroinflammation and central nervous system diseases

Xu, W., Huang, Y., & Zhou, R. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01275-w · Cited by 355

Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control

Próchnicki, T., & Latz, E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.018 · Cited by 302

Focus on the Role of NLRP3 Inflammasome in Diseases

Fusco, R., Siracusa, R., Genovese, T., Cuzzocrea, S., & Paola, R. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124223 · Cited by 301

Systemic Inflammatory Response Syndrome After Surgery: Mechanisms and Protection

Margraf, A., Ludwig, N., Zarbock, A., & Rossaint, J. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005175 · Cited by 310

Toward targeting inflammasomes: insights into their regulation and activation

Christgen, S. L., Place, D. E., & Kanneganti, T. (2020) · Cell Research · doi:10.1038/s41422-020-0295-8 · Cited by 290

NLRP3: A promising therapeutic target for autoimmune diseases

Shen, H., Yang, Y., Meng, X. L., Luo, X., Li, X., Shuai, Z., Ye, D., & Pan, H. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.01.020 · Cited by 271

Spotlight on the NLRP3 inflammasome pathway

Groslambert, M., & Py, B. F. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s141220 · Cited by 279

Role of the NLRP3 inflammasome in autoimmune diseases

Li, Z., Guo, J., & Bi, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110542 · Cited by 276

Depression and anxiety in patients with active ulcerative colitis: crosstalk of gut microbiota, metabolomics and proteomics

Yuan, X., Chen, B., Duan, Z., Xia, Z., Ding, Y., Chen, T., Liu, H., Wang, B., Yang, B., Wang, X., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1987779 · Cited by 273

NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations

Mortimer, L. M., Moreau, F., MacDonald, J. A., & Chadee, K. (2016) · Nature Immunology · doi:10.1038/ni.3538 · Cited by 272

Prussian Blue Nanozyme as a Pyroptosis Inhibitor Alleviates Neurodegeneration

Ma, X., Hao, J., Wu, J., Li, Y., Cai, X., & Zheng, Y. (2022) · Advanced Materials · doi:10.1002/adma.202106723 · Cited by 257

The Crohn’s Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by Impeding Its Assembly and by Mediating Its Selective Autophagy

Mehto, S., Jena, K. K., Nath, P., Chauhan, S., Kolapalli, S. P., Das, S. K., Sahoo, P. K., Jain, A., Taylor, G. A., & Chauhan, S. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.11.018 · Cited by 238

How location and cellular signaling combine to activate the NLRP3 inflammasome

Akbal, A., Dernst, A., Lovotti, M., Mangan, M., McManus, R. M., & Latz, E. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00922-w · Cited by 259

The role of inflammasomes in human diseases and their potential as therapeutic targets

Yao, J., Sterling, K., Wang, Z., Zhang, Y., & Song, W. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01687-y · Cited by 260

Targeting the Microglial NLRP3 Inflammasome and Its Role in Parkinson's Disease

Haque, M. E., Akther, M., Jakaria, M., Kim, I., Azam, S., & Choi, D. (2019) · Movement Disorders · doi:10.1002/mds.27874 · Cited by 251

STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection

Wang, W., Hu, D., Feng, Y., Wu, J., Li, A., Wang, Y., Cheng, K., Tian, M., Xiao, F., Zhang, Q., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008335 · Cited by 240

The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases

de Torre‐Minguela, C., Mesa-del-Castillo, P., & Pelegrín, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00043 · Cited by 251

NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma

McKee, C. M., & Coll, R. C. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0720-513r · Cited by 246

SUMO-mediated regulation of NLRP3 modulates inflammasome activity

Barry, R. E., John, S. W., Liccardi, G., Tenev, T., Jaco, I., Chen, C., Choi, J. C.-B., Kasperkiewicz, P., Fernandes‐Alnemri, T., Alnemri, E. S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05321-2 · Cited by 240

Microglial Autophagy Defect Causes Parkinson Disease-like Symptoms by Accelerating Inflammasome Activation in Mice

Cheng, J., Liao, Y., Dong, Y., Hu, H., Yang, N., Kong, X., Li, S., Li, X., Guo, J., Qin, L., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1719723 · Cited by 233

Role of pyroptosis in spinal cord injury and its therapeutic implications

Mamun, A. A., Wu, Y., Monalisa, I., Jia, C., Zhou, K., Munir, F., & Xiao, J. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.08.004 · Cited by 232

Inflammasomes as therapeutic targets in human diseases

Li, Y., Huang, H., Liu, B., Zhang, Y. L., Pan, X., Yu, X., Shen, Z., & Song, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00650-z · Cited by 238

The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target

O’Brien, W. T., Pham, L., Symons, G. F., Monif, M., Shultz, S. R., & McDonald, S. J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01778-5 · Cited by 233

Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease

Ahmed, S., Kwatra, M., Panda, S. R., Murty, U. S. N., & Naidu, V. G. M. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.09.017 · Cited by 217

Curcumin Suppresses IL-1β Secretion and Prevents Inflammation through Inhibition of the NLRP3 Inflammasome

Yin, H., Guo, Q., Li, X., Tang, T., Li, C., Wang, H., Sun, Y., Feng, Q., Ma, C., Gao, C., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701495 · Cited by 214

The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease

Zhang, C., Zhao, M., Wang, B., Su, Z., Guo, B., Qin, L., Zhang, W., & Zheng, R. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102134 · Cited by 208

Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance

Yu, J., & Lee, M. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0827-4 · Cited by 209

Hydrogen inhibits endometrial cancer growth via a ROS/NLRP3/caspase-1/GSDMD-mediated pyroptotic pathway

Yang, Y., Liu, P. Y., Bao, W., Chen, S. J., Wu, F. S., & Zhu, P. (2020) · BMC Cancer · doi:10.1186/s12885-019-6491-6 · Cited by 203

Post-translational regulation of inflammasomes

Yang, J., Liu, Z., & Xiao, T. S. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.29 · Cited by 211

Lipopolysaccharide Primes the NALP3 Inflammasome by Inhibiting Its Ubiquitination and Degradation Mediated by the SCFFBXL2 E3 Ligase

Han, S., Lear, T., Jerome, J. A., Rajbhandari, S., Snavely, C. A., Gulick, D. L., Gibson, K. F., Zou, C., Chen, B. B., & Mallampalli, R. K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.645549 · Cited by 207

Multiple roles of caspase-8 in cell death, inflammation, and innate immunity

Ørning, P., & Lien, E. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0420-305r · Cited by 206

Neurodegenerative Disease and the NLRP3 Inflammasome

Holbrook, J. A., Jarosz-Griffiths, H., Caseley, E. A., Reyna, S. J. L., Poulter, J. A., Williams‐Gray, C. H., Peckham, D. G., & McDermott, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.643254 · Cited by 201

Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases

Xu, C., Lu, Z.-D., Luo, Y., Liu, Y., Cao, Z., Shen, S., Li, H., Liu, J., Chen, K., Chen, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06522-5 · Cited by 199

The NLRP3–inflammasome as a sensor of organelle dysfunction

Seoane, P. I., Lee, B., Hoyle, C., Yu, S., Lopez-Castejon, G., Lowe, M., & Brough, D. (2020) · Journal of Cell Biology · doi:10.1083/jcb.202006194 · Cited by 190

β-amyloid, microglia, and the inflammasome in Alzheimer’s disease

Gold, M., & El Khoury, J. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0518-0 · Cited by 187

The E3 ubiquitin ligase Pellino2 mediates priming of the NLRP3 inflammasome

Humphries, F., Bergin, R., Jackson, R. P., Delagic, N., Wang, B., Yang, S., Dubois, A. V., Ingram, R. J., & Moynagh, P. N. (2018) · Nature Communications · doi:10.1038/s41467-018-03669-z · Cited by 197

Targeting the NLRP3 inflammasome to attenuate spinal cord injury in mice

Jiang, W., Li, M., He, F., Zhou, S., & Zhu, L. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0980-9 · Cited by 186

NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s disease

von Herrmann, K. M., Salas, L. A., Martinez, E. M., Young, A. L., Howard, J. M., Feldman, M. S., Christensen, B. C., Wilkins, O. M., Lee, S., Hickey, W. F., et al. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0061-5 · Cited by 190

Anhedonia in depression: biological mechanisms and computational models

Cooper, J. A., Arulpragasam, A. R., & Treadway, M. T. (2018) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2018.01.024 · Cited by 208

Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis

Qiao, L., Ma, J., Zhang, Z., Sui, W., Zhai, C., Xu, D., Wang, Z., Lu, H., Zhang, M., Zhang, C., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.318908 · Cited by 186

Programmed Necrosis and Disease:We interrupt your regular programming to bring you necroinflammation

Kim, E. H., Wong, S., & Martinez, J. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0179-3 · Cited by 181

Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950

Corcoran, S. E., Halai, R., & Cooper, M. A. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000171 · Cited by 180

Recent insights into the molecular mechanisms of the NLRP3 inflammasome activation

Próchnicki, T., Mangan, M., & Latz, E. (2016) · F1000Research · doi:10.12688/f1000research.8614.1 · Cited by 174

Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer

Tan, Y., Sun, R., Liu, L., Yang, D., Xiang, Q., Li, L., Tang, J., Qiu, Z., Peng, W., Wang, Y., et al. (2021) · Theranostics · doi:10.7150/thno.58322 · Cited by 177

The World Goes Bats: Living Longer and Tolerating Viruses

Gorbunova, V., Seluanov, A., & Kennedy, B. K. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.013 · Cited by 162

Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of β-arrestin2 and NLRP3

Zhu, J., Hu, Z., Han, X., Wang, D., Jiang, Q., Ding, J., Xiao, M., Wang, C., Lu, M., & Hu, G. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0127-2 · Cited by 179

The Regulation of Immunological Processes by Peripheral Neurons in Homeostasis and Disease

Ordovás-Montañés, J., Rakoff-Nahoum, S., Huang, S., Riol‐Blanco, L., Barreiro, O., & von Andrian, U. H. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.08.007 · Cited by 178

The lipid peroxidation product 4-hydroxynonenal inhibits NLRP3 inflammasome activation and macrophage pyroptosis

Hsu, C. G., Chávez, C. L., Zhang, C., Sowden, M. P., Chen, Y., & Berk, B. C. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00966-5 · Cited by 174

Cellular and molecular regulation of innate inflammatory responses

Liu, J., & Cao, X. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.58 · Cited by 171

TRIM28 SUMOylates and stabilizes NLRP3 to facilitate inflammasome activation

Qin, Y., Li, Q., Liang, W., Yan, R., Li, T., Jia, M., Zhao, C., & Zhao, W. (2021) · Nature Communications · doi:10.1038/s41467-021-25033-4 · Cited by 180

Structure, Activation and Regulation of NLRP3 and AIM2 Inflammasomes

Sharma, M., & de Alba, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020872 · Cited by 173

MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis

Li, S., Liang, X., Ma, L., Shen, L., Li, T., Zheng, L., Sun, A., Shang, W., Chen, C., Zhao, W., et al. (2017) · Oncogene · doi:10.1038/onc.2017.381 · Cited by 161

Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome

Xiao, L., Liu, Q., Luo, M., & Xiong, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.729346 · Cited by 168

Mitochondrial Stress-Initiated Aberrant Activation of the NLRP3 Inflammasome Regulates the Functional Deterioration of Hematopoietic Stem Cell Aging

Luo, H., Mu, W.-C., Karki, R., Chiang, H.-H., Mohrin, M., Shin, J. J., Ohkubo, R., Ito, K., Kanneganti, T.-D., & Chen, D. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.101 · Cited by 161

Inflammasomes: Threat-Assessment Organelles of the Innate Immune System

Evavold, C. L., & Kagan, J. C. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.005 · Cited by 159

YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3

Wang, D., Zhang, Y., Xu, X., Wu, J., Peng, Y., Li, J., Luo, R., Huang, L., Liu, L., Yu, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22987-3 · Cited by 160

The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson’s Disease in Rats

Mao, Z., Liu, C., Ji, S., Yang, Q., Ye, H., Han, H., & Xue, Z. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2185-0 · Cited by 155

Parkin deficiency modulates NLRP 3 inflammasome activation by attenuating an A 20‐dependent negative feedback loop

Mouton‐Liger, F., Rosazza, T., Sepulveda‐Diaz, J., Ieang, A., Hassoun, S., Claire, E., Mangone, G., Brice, A., Michel, P. P., Corvol, J., et al. (2018) · Glia · doi:10.1002/glia.23337 · Cited by 160

Dopamine blocks inflammasome activation

Bordon, Y. (2015) · Nature reviews. Immunology · doi:10.1038/nri3817

Dopamine controls NLRP3

Dempsey, L. A. (2015) · Nature Immunology · doi:10.1038/ni.3110

The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases

Possemato, E., Barbera, L. L., Nobili, A., Krashia, P., & D’Amelio, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101907 · Cited by 76

Anti-inflammatory Effects of Dopamine in Lipopolysaccharide (LPS)-stimulated RAW264.7 Cells via Inhibiting NLRP3 Inflammasome Activation.

Liu, A., & Ding, S. (2019) · PubMed · Cited by 24

Dual Impact of Dopamine on NLRP3 Inflammasome: Priming Signal and Mitochondria-Mediated Activation in Human Monocyte-Derived Macrophages (Abstract ID: 159736)

Daniali, M., Channer, B., Matt, S. M., Kist, T., & Gaskill, P. J. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2024.100662